CMS advises Bruker on the multi-jurisdictional acquisition of ELITech, an In Vitro Diagnostics Systems Group
Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.
A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands.
ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases.
ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany.
CMS Germany
Dr Hendrik Hirsch, Partner, Co-Lead
Dr Jacob Siebert, Partner, Co-Lead
Dr Dirk Baukholt, Principal Counsel
Dr Berrit Roth-Mingram, Counsel
Dr Maximilian Stark, Senior Associate, all Corporate/M&A
Dr Roland Wiring, Partner
Lukas Burgdorff, Associate
Noah Rodenkirchen, Associate, all Regulatory & Lifesciences
Dr Thomas Hirse, Partner
Sebastian Vautz, Senior Associate
Lisa Dietrich, Associate, all IP
Dr Michael Bauer, Partner
Stefan Lehr, Partner
Kai Neuhaus, Partner
Moritz Pottek, Counsel
Dr. Denis Schlimpert, Counsel
Kirsten Baubkus-Gerard, Senior Associate
David Rappenglück, Associate
Benedikt Christian Voss, Associate, all Antitrust, Competition & Trade
Dr Thomas de la Motte, Partner
Dr Markus Pfaff, Partner
Dr André Frischemeier, Partner
Hatice Aykel, Counsel
Alisa Brehm, Senior Associate
Thomas Schaak, Senior Associate
Dr Sait Dogan, Associate, all Banking & Finance
Dr André Lippert, Partner
Constanze Schweidtmann, Associate, both Real Estate & Public
Dr Boris Alles, Partner
Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions
CMS France
Benoît Gomel, Partner
Vincent Desbenoit, Associate
Dylan Allali, all Corporate/M&A
Caroline Froger-Michon, Partner
Aurélie Parchet, Associate
Camille Baumgarten, Associate
Sophie Yin, all Employment
Claire Vannini, Partner
Eleni Moraïtou, Counsel
Lilia-Oriana Dif, Associate
Ariane Rolin, all Competition & EU
Jean-Baptiste Thiénot, Partner
Anaïs Arnal, Associate, both Intellectual Property
Laurine Mayer, Associate, TMC
Alexandre Chazot, Counsel, Banking & Finance
Thierry Granier, Partner
Renaud Grob, Partner, both Tax
Arnaud Valverde, Senior Associate, Real Estate
Olivier Kuhn, Partner
Cécile Rebiffé, Counsel
Mylène Garrouste, all Dispute Resolution
Kawthar Ben Khelil, Counsel
Jean-Pierre Malili, Associate, both Public law/Infrastructure
CMS Italy
Massimo Trentino, Partner, Corporate/M&A
Maria Letizia Patania, Partner, Lifescience & Healthcare
Gian Marco Lettieri, Senior Associate, Employment & Pensions
Giulio Poggioli, Counsel
Valerio Giuseppe Daniele, Associate
Francesca Durante, Junior Associate
Arianna Toccaceli, Junior Associate, all Banking & Finance
CMS Luxembourg
Gérard Maitrejean, Partner
Miruna Poenaru, Counsel
Maximilian Helfgen, Associate, all Corporate/M&A
CMS UK
Jack Letson, Partner
Lindsay McAllister, Associate, both Corporate/M&A
David Dennis, Partner, Commercial
CMS Netherlands
Pieter van Duijvenvoorde, Partner
Robert Jong, both Corporate/M&A
Nigel Henssen
Fleur van Assendelft de Coningh, both Employment
Edmon Oude Elferink, Partner
Marijke van der Vossen, both Antitrust, Competition & Trade
CMS Serbia
Radivoje Petrikić, Partner
Mila Drljević, both Corporate/M&A
CMS Austria
Dieter Zandler, Partner
Vanessa Horaceck, both Competition & EU
CMS Ukraine
Maria Orlyk, Partner
Diana Valyeyeva
CMS Turkiye
Döne Yalçın, Partner
Arcan Kemahlı,
Sabahattin Öztemiz
Taner Elmas
Press Contact
presse@cms-hs.com
